Edward Livant

1.8k citations

15 papers · 275 indexed · h-index 9

Virology top 5%
- HIV Research and Treatment 7
Microbiology top 10%
- Reproductive tract infections research 3
Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 10
- HIV/AIDS drug development and treatment 2
Epidemiology
- HIV, Drug Use, Sexual Risk 4
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Breastfeeding Practices and Influences 1
General Health Professions
- Adolescent Sexual and Reproductive Health 3

Co-authors: Marla Husnik Barbra A. Richardson Cindy Jacobson Clare F. Price Beatrice A. Chen Ian McGowan Irma Febo Karen Bruder
Cited by: Virology Microbiology Infectious Diseases
Journals: PLoS ONE (1 paper)Clinical Infectious Diseases (1 paper)The Journal of Infectious Diseases (1 paper)
Partner nations: United States Uganda South Africa

In The Last Decade

Edward Livant

13 papers receiving 270 citations

Peers

Countries citing papers authored by Edward Livant

Since Specialization

Citations

This map shows the geographic impact of Edward Livant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Livant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Livant more than expected).

Fields of papers citing papers by Edward Livant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Livant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Livant. The network helps show where Edward Livant may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edward Livant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Livant Line = papers co-authored together Edward Livant links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial The Lancet HIV ·Lisa Noguchi,Maxensia Owor,Nyaradzo Mgodi,Brenda Gati Mirembe,Sufia Dadabhai,Elizea Horne,Holly Gundacker,Barbra A. Richardson,Katherine Bunge,Rachel Scheckter,Mei Song,Mark A. Marzinke,Peter L. Anderson,Edward Livant,Cindy Jacobson,Jeanna Piper,Nahida Chakhtoura,Sharon L. Hillier,Jennifer E. Balkus	2025	3
2	Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015 UNC Libraries ·Vanessa Elharrar,Sharon A. Riddler,Edward Livant,Arendevi Pather,Francis Martinson,Felix Muhlanga,Jennifer E. Balkus,Marla Husnik,Urvi M. Parikh,MTN- Protocol Team for the Microbicide Trials Network,Pamina M. Gorbach,Margaret P. Kasaro,Lisa Levy,Bonus Makanani	2024	0
3	Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence AIDS and Behavior ·Marla Husnik,Renee Heffron,James P. Hughes,Barbra A. Richardson,Ariane van der Straten,Thesla Palanee‐Phillips,Lydia Soto‐Torres,Devika Singh,Brenda Gati Mirembe,Edward Livant,Zakir Gaffoor,Leila E. Mansoor,Samantha Siva,Sufia Dadabhai,Flavia Matovu Kiweewa,Jared M. Baeten,(unknown)	2024	0
4	Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women The Journal of Infectious Diseases ·Sujatha Srinivasan,Barbra A. Richardson,Jacqueline Mae Wallis,Tina L. Fiedler,Susan Strenk,Noah G. Hoffman,Sean Proll,Zvavahera M. Chirenje,Edward Livant,David N. Fredricks,Sharon L. Hillier,Jeanne Marrazzo	2024	5
5	Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring Clinical Infectious Diseases ·Sharon A. Riddler,Jennifer E. Balkus,Urvi M. Parikh,John W. Mellors,Carolyne A. Akello,Sufia Dadabhai,Felix Mhlanga,Gita Ramjee,Ashley Mayo,Edward Livant,Amy Heaps,Colin O’Rourke,Jared M. Baeten,(unknown)	2018	11
6	Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations AIDS Research and Human Retroviruses ·Catherine A. Koss,Peter Bacchetti,Sharon L. Hillier,Edward Livant,Howard Horng,Nyaradzo Mgodi,Brenda Gati Mirembe,Kailazarid Gomez Feliciano,Stephanie Van Horn,Albert Liu,David V. Glidden,Robert M. Grant,Leslie Z. Benet,Alexander Louie,Ariane van der Straten,Zvavahera M. Chirenje,Jeanne Marrazzo,Monica Gandhi,on behalf of the MTN- Protocol T	2017	50
7	HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial PLoS ONE ·Sharon A. Riddler,Marla Husnik,Gita Ramjee,Anamika Premrajh,Bomkazi Tutshana,Arendevi Pather,Samantha Siva,Nitesha Jeenarain,Gonasagrie Nair,Pearl Selepe,Samuel Kabwigu,Thesla Palanee‐Phillips,Ravindre Panchia,Felix Mhlanga,Lisa Levy,Edward Livant,Karen Patterson,Vanessa Elharrar,Jennifer E. Balkus	2017	3
8	The fourth generation Alere TM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples Journal of Clinical Virology ·Edward Livant,Amy Heaps,Cliff Kelly,Rashika Maharaj,Natasha Samsunder,Lindiwe Nhlangulela,Patrick Karugaba,Ravindre Panchia,Jeanne Marrazzo,Zvavahera M. Chirenje,Urvi M. Parikh	2017	21
9	Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial JAIDS Journal of Acquired Immune Deficiency Syndromes ·Marla Husnik,Elizabeth R. Brown,Mark A. Marzinke,Edward Livant,Thesla Palanee‐Phillips,Craig W. Hendrix,Flavia Matovu Kiweewa,Gonasagrie Nair,Lydia Soto‐Torres,Katie Schwartz,Sharon L. Hillier,Jared M. Baeten,(unknown)	2017	11
10	Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015 HIV Clinical Trials ·Sharon A. Riddler,Marla Husnik,Pamina M. Gorbach,Lisa Levy,Urvi M. Parikh,Edward Livant,Arendevi Pather,Bonus Makanani,Felix Muhlanga,Margaret P. Kasaro,Francis Martinson,Vanessa Elharrar,Jennifer E. Balkus,(unknown)	2016	5
11	Factors associated with bone mineral density in healthy African women Archives of Osteoporosis ·(unknown),Nyaradzo Mgodi,Clifton W. Kelly,Brenda Gati,Susan L. Greenspan,James Y. Dai,Vivian Bragg,Edward Livant,Jeanna Piper,Clemensia Nakabiito,Tsitsi Magure,Jeanne Marrazzo,Zvavahera M. Chirenje,Sharon A. Riddler	2015	17
12	Association of Tenofovir (TFV) Detection with Reduced Risk of Herpes Simplex virus Type-2 (HSV-2) Acquisition in the VOICE (MTN 003) Study AIDS Research and Human Retroviruses ·Jeanne Marrazzo,Lorna K. Rabe,Cliff Kelly,Edward Livant,Zvavahera M. Chirenje,Barbra A. Richardson,James Y. Dai,Jeanna Piper,Sharon L. Hillier,(unknown)	2014	10
13	Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) AIDS ·Ian McGowan,Kailazarid Gomez,Karen Bruder,Irma Febo,Beatrice A. Chen,Barbra A. Richardson,Marla Husnik,Edward Livant,Clare F. Price,Cindy Jacobson	2011	102
14	Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India. PubMed ·K Murugavel,Pachamuthu Balakrishnan,Janardhanan Mohanakrishnan,Suniti Solomon,Esaki M. Shankar,Sandeep Pulimi Muthu Sundaram,Nagalingeswaran Kumarasamy,Estelle Piwowar‐Manning,Edward Livant,K. H. Mayer,S P Thyagarajan	2009	12
15	Ethnic variation in certain hematological and biochemical reference intervals in a south Indian healthy adult population European Journal of Internal Medicine ·M. Sundaram,Janardhanan Mohanakrishnan,K Murugavel,Esaki M. Shankar,S Solomon,C.N. Srinivas,Sandeep Pulimi,Estelle Piwowar‐Manning,Sierra Dawson,Edward Livant,N. Kumarasamy,Pachamuthu Balakrishnan	2007	25

About Edward Livant

Edward Livant is a scholar working on Virology, Infectious Diseases and Microbiology, having authored 15 papers that have together received 275 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (7 papers), HIV, Drug Use, Sexual Risk (4 papers), Reproductive tract infections research (3 papers), Adolescent Sexual and Reproductive Health (3 papers), HIV/AIDS drug development and treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Breastfeeding Practices and Influences (1 paper). The work is most often cited by research in Virology (93 citations), Microbiology (53 citations) and Infectious Diseases (149 citations). Edward Livant has collaborated with scholars based in United States, Uganda and South Africa. Frequent co-authors include Marla Husnik, Barbra A. Richardson, Cindy Jacobson, Clare F. Price, Beatrice A. Chen, Ian McGowan, Irma Febo, Karen Bruder, Kailazarid Gomez and Zvavahera M. Chirenje. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact